Francesca Barone
2021
In 2021, Francesca Barone earned a total compensation of $364.8K as Chief Scientific Officer at Candel Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $101,500 |
|---|---|
| Salary | $259,728 |
| Other | $3,569 |
| Total | $364,797 |
Barone received $259.7K in salary, accounting for 71% of the total pay in 2021.
Barone also received $101.5K in non-equity incentive plan and $3.6K in other compensation.
Rankings
In 2021, Francesca Barone's compensation ranked 11,322nd out of 12,415 executives tracked by ExecPay. In other words, Barone earned more than 8.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,322 out of 12,415 | 9th |
Division Manufacturing | 5,005 out of 5,508 | 9th |
Major group Chemicals And Allied Products | 2,218 out of 2,378 | 7th |
Industry group Drugs | 1,972 out of 2,099 | 6th |
Industry Biological Products, Except Diagnostic Substances | 427 out of 449 | 5th |
Source: SEC filing on May 23, 2023.
Barone's colleagues
We found three more compensation records of executives who worked with Francesca Barone at Candel Therapeutics in 2021.